ARS Pharmaceuticals【SPRY】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

11.18

買値

11.02

売値

11.74

出来高

2,501,777

10.83 日の範囲 11.5645

5.02 52 週間の範囲 18.49

時価総額

1.087B

前日終値

11.32

始値

11.205

時刻

11.73

最終取引時間

財務取引量

US$ 28,139,515

VWAP

11.2478

平均取引量 (3 か月)

1,061,351

発行済株式数

97,185,475

配当利回り

PER

-20.02

1 株当たり利益 (EPS)

-0.56

歳入

30k

純利益

-54.37M

ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for pa... ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

ars-pharma.com

本社

Wilmington, Delaware, USA

設立

ARS Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker SPRY. The last closing price for ARS Pharmaceuticals was US$11.32. Over the last year, ARS Pharmaceuticals shares have traded in a share price range of US$ 5.02 to US$ 18.49.

ARS Pharmaceuticals currently has 97,185,475 shares in issue. The market capitalisation of ARS Pharmaceuticals is US$1.10 billion. ARS Pharmaceuticals has a price to earnings ratio (PE ratio) of -20.02.

ARS Pharmaceuticals Announces neffy® (Epinephrine Nasal Spray) is available on Express Scripts Commercial National Formularies

Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024 and expands access to patients and caregivers managing Type 1 Allergic Reactions SAN DIEGO, Dec. 19...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-1.48	-11.6903633491	12.66	12.66	10.6275	1201302	11.45823451	CS
4	-2.205	-16.4736645499	13.385	14.9	10.6275	1018420	12.87981403	CS
12	-3.37	-23.1615120275	14.55	18.49	10.6275	1061351	14.44912308	CS
26	3.12	38.7096774194	8.06	18.49	7.55	1077880	13.0655222	CS
52	5.92	112.547528517	5.26	18.49	5.02	809141	11.56687833	CS
156	5.9	111.742424242	5.28	18.49	2.55	723113	8.72068777	CS
260	5.9	111.742424242	5.28	18.49	2.55	723113	8.72068777	CS

SPRY - Frequently Asked Questions (FAQ)

What is the current ARS Pharmaceuticals share price?

The current share price of ARS Pharmaceuticals is US$ 11.18

How many ARS Pharmaceuticals shares are in issue?

ARS Pharmaceuticals has 97,185,475 shares in issue

What is the market cap of ARS Pharmaceuticals?

The market capitalisation of ARS Pharmaceuticals is USD 1.1B

What is the 1 year trading range for ARS Pharmaceuticals share price?

ARS Pharmaceuticals has traded in the range of US$ 5.02 to US$ 18.49 during the past year

What is the PE ratio of ARS Pharmaceuticals?

The price to earnings ratio of ARS Pharmaceuticals is -20.02

What is the cash to sales ratio of ARS Pharmaceuticals?

The cash to sales ratio of ARS Pharmaceuticals is 37.33k

What is the reporting currency for ARS Pharmaceuticals?

ARS Pharmaceuticals reports financial results in USD

What is the latest annual turnover for ARS Pharmaceuticals?

The latest annual turnover of ARS Pharmaceuticals is USD 30k

What is the latest annual profit for ARS Pharmaceuticals?

The latest annual profit of ARS Pharmaceuticals is USD -54.37M

What is the registered address of ARS Pharmaceuticals?

The registered address for ARS Pharmaceuticals is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801

What is the ARS Pharmaceuticals website address?

The website address for ARS Pharmaceuticals is ars-pharma.com

Which industry sector does ARS Pharmaceuticals operate in?

ARS Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
MYSZMy Size Inc	US$ 4.2001 (211.12%)	120.01M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	76.64M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	33.95M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.61k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	120.4M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.32M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	305.1M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	292.16M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	287.21M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	277.63M